Search results (71)
« Back to News and opinionNew Oxford Study Shows Brief Sleep Therapy Delivered by Nurses Improves Insomnia
11 August 2023
Cardiovascular & metabolic Clinical trials Policy & health systems
Researchers from the University of Oxford have found that a brief form of cognitive behavioural therapy (CBT) for insomnia, delivered by nurses in GP surgeries, significantly improves sleep and quality of life compared to sleep hygiene alone.
Rapid weight loss found to be safe and helpful for people with liver disease, Oxford trial reveals
28 June 2023
Cardiovascular & metabolic Clinical trials Health behaviours
A clinical trial, led by a team at NDPCHS, has shown that a three-month rapid weight loss programme was not only safe but also effective in reducing the severity of a liver disease called non-alcoholic steatohepatitis (NASH) with liver fibrosis.
Multi-cancer blood test showed ‘real promise’ in NHS trial
2 June 2023
An NHS trial of a new blood test for more than 50 types of cancer, led by the University of Oxford, correctly revealed two out of every three cancers among over 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.
Introducing Proxemis: the University of Oxford and EMIS have announced a new joint venture, Proxemis, an end-to-end clinical trial solution
4 May 2023
Clinical trials Digital health & innovation
Combining the world-renowned expertise of the Nuffield Department of Primary Care Health Science's Clinical Trials Unit with the software and data management capabilities of EMIS, Proxemis is reimagining research to support healthier lives with a uniquely tailored experience for clinical trial delivery.
Professor Chris Butler addresses the UN on PANORAMIC - BAPS UK & Europe collaboration
24 January 2023
COVID-19 Clinical trials Public engagement & involvement
Recently, Professor Chris Butler addressed the United Nations regarding the PANORAMIC Trial and the assistance of BAPS UK & Europe.
PANORAMIC trial finds molnupiravir does not reduce COVID-19 hospitalisation/deaths in vaccinated people at high risk
22 December 2022
Researchers from the University of Oxford have today released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial.
Clinical Trials Day 20 May 2022 - “We couldn’t do it without you.”
17 May 2022
Clinical Trials Day gives us an opportunity to reflect on, and appreciate, recent achievements and the people who have made these achievements possible. So, this year we want to say a big thank you to everyone involved, “we couldn’t do it without you”.
The PRINCIPLE Trial - two years on
16 May 2022
The PRINCIPLE Trial has led the way in evaluating treatments for COVID-19 in the community over the last two years.
Self-monitoring of blood pressure does not result in the earlier detection of high blood pressure in pregnancy nor does it improve blood pressure control in those with pregnancy hypertension
3 May 2022
Clinical trials Patient experience
Self-monitoring of blood pressure during pregnancy neither results in earlier detection of high blood pressure, nor helps with blood pressure control in those who are pregnant, suggest the results of two new papers based on research from the University of Oxford and King’s College London (funded by the National Institute of Health and Care Research).
Primary care research nurses nominated for OUH Award
13 April 2022
Awards & appointments COVID-19 Clinical trials
Congratulations to the amazing team of research nurses working in the Primary Care Clinical Trials Unit who have been shortlisted as finalists in the Oxford University Hospitals NHS Foundation Trust Staff Recognition Awards 2021.
10,000 people join the PRINCIPLE Trial – A huge ‘Thank You’ from us all.
4 April 2022
10,000 people have joined the PRINCIPLE Trial over the last two years and we want to say a big ‘Thank You’ to them all for their amazing contribution to testing treatments for COVID-19 in the community.
PANORAMIC hits the 20,000 participant milestone
31 March 2022
The world’s largest study of community-based treatments for acute COVID-19 has reached a world-first, historic milestone: over twenty thousand participants from across the UK have now taken part in the PANORAMIC trial.
Recruitment begins for national community COVID-19 antiviral trial
8 December 2021
COVID-19 Clinical trials Public engagement & involvement
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
PRINCIPLE trial 'highly commended' for innovative use of health data
5 July 2021
Big data COVID-19 Clinical trials
The PRINCIPLE trial has been highly commended at the Health Data Research UK Awards for the way in which patient data is utilised so participants are contacted about the trial soon after receiving a positive test result.
Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial
23 June 2021
COVID-19 Clinical trials Infection & acute care
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
Celebrating International Clinical Trials Day 2021
20 May 2021
Each year, International Clinical Trials Day recognises the people who conduct clinical trials, giving our community a chance to say thank you for everything they do to improve public health. This year our trials unit staff are sharing what makes them proud to be part of Oxford’s Primary Care Clinical Trials Unit.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
12 April 2021
COVID-19 Clinical trials Infection & acute care
Inhaled budesonide, a common corticosteroid, is the world's first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. As of today, the treatment is available in UK primary care on a case-by-case basis.
Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial
8 April 2021
COVID-19 Clinical trials Infection & acute care
Could the antiviral favipiravir help transform COVID-19 into an illness that can be successfully treated by general practitioners?
Blog: Opinions from our research and teaching
Contact our communications team
Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.